Sumitomo Pharma's Sustainability.
Top Management Commitment
Sumitomo Pharma’s approach to sustainability is firmly rooted in “value creation.”
We will continue to develop innovative pharmaceuticals and healthcare solutions to solve the challenges
in healthcare, and contribute to the betterment of healthcare and fuller lives of people worldwide.
We will contribute to the realization of a sustainable society and leads to the sustained enhancement
of our corporate values through the practice of our Mission.
Promoting Healthcare Innovation
With a focus on the Psychiatry & Neurology and Oncology as priority disease areas, Sumitomo Pharma Group will contribute to improving not just the treatments of patients but also the QOL (quality of life) of patients and their families, through diverse approaches, including pharmaceutical products, regenerative medicine/cell therapy, and non-pharmaceutical solutions.
- Development of Innovative Products and Healthcare Solutions
- Research and Development
- Respect for Intellectual Property
- Provision of Stable Supplies
- CSR-Based Procurement
- Sustainable Code of Conduct for Business Partners
- Fair Marketing
- Corporate Regulatory Compliance and Quality Assurance
- Medical Science
We will proactively make concerted efforts to preserve the environment and help creating a circular society
through all its corporate activities, thereby contributing to realizing a sustainable society.
We seek to realize a prosperous society where everyone can achieve success based on their individuality.
Every employee conducts transparent and fair corporate activities with the highest level of ethics.